See how public and private biotech investors are performing with deal-level returns data, exit proceeds, check sizes and performance metrics for thousands of public and private biotech investors.
Trusted by university endowments, top-tier consulting firms and leading biotech investors.
Analyze portfolio concentration and returns distribution. Which funds returned with a single investment? Which funds hit consistent doubles and triples?
Analyze fund strategy and competitiveness with valuations and check size data for hundreds of rounds.
Break down fund portfolios by therapeutic area, development stage, location and deal stage.
Details on investment activity since January 2018, including therapeutic area, stage and co-investors.
Biopharma-focused M&A, IPO and venture comps covering hundreds of billions of dollars in investments and exits.